Back

Validity and reliability of an smartwatch single-lead ECG for monitoring QT interval prolongation: an interventional study with moxifloxacin

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Poster session (3): mechanisms and management of arrhythmias Wearables and m-Health EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Leendert Hoek

ICON - Health Sciences Research Centre Martini, Groningen (Netherlands (The))

196 More presentations in this session

Presentation thumbnail
Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects
Doctor J. Uutela (Jyvaskyla, FI)
Abstract
Presentation thumbnail
A wearable SCG-based approach for early, low-cost screening of valvular heart disease
Doctor V. Pergola (Naples, IT)
Presentation thumbnail
Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study
Doctor B. Hrymniak (Wroclaw, PL)
Abstract
Presentation thumbnail
Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance
Doctor Y. Shhab (Bucharest, RO)
Abstract
Presentation thumbnail
Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort
Ms A. Bondoc (Timisoara, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

12 April - 14 April 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources